Enter your login e-mail to the account
Search
Search parameters
Search results
- Current scientific knowledge about NAFLD/MAFLD during the COVID-19 pandemic and the benefits of essential phospholipids in the treatment of hepatic steatosis
doc. MUDr. Peter Minárik, PhD., MSc, prof. PharmDr. Ján Kyselovič, CSc., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Zuzana Paraličová, PhD., prof. MUDr. Peter Jarčuška, PhD.
(4/2022, Review articles ) - The management of non-alcoholic fatty liver disease
prof. MUDr. Jozef Holomáň, CSc., doc. MUDr. Mária Szántová, PhD., Doc. MUDr. Martin Zima, PhD., PharmDr. Ľubica Slobodová
(5/2016, Topic of the year ) - Diabesity and liver diseases
MUDr. Marek Rác, PhD.
(2/2021, Topic of the year ) - NONALCOHOLIC FATTY LIVER DISEASE
MUDr. Martin Zima, PhD.
(4-5/2008, Topic ) - ELEVATED „LIVER ENZYMES“ IN HEPATOLOGIC OFFICE/CLINICAL PRACTICE – CASE REPORTS
prof. MUDr. Jozef Holomáň, CSc.
(4-5/2008, From practice ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Effective drug therapy of liver diseases in general practice
doc. MUDr. Radan Brůha, CSc.
(1/2014, Review articles ) - RELATIONSHIP OF VISCERAL OBESITY TO CARDIOMETABOLIC RISK FACTORS
MUDr. Ľubomíra Fábryová, PhD.
(3/2008, Topic )